The Behavioral and Neuroinflammatory Impact of Ketamine in a Murine Model of Depression and Liver Damage
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26083558 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mădălina Iuliana Mușat und 4 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Research Centre for Normal and Pathological Aging, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania. Hauptthemen laut MEDLINE: Ketamine, Depression, Behavior, Animal, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy of Craiova, University of Medicine and Pharmacy of Craiova, Romania.
Themen: Depression
Abstract (Originalsprache)
Non-alcoholic fatty liver disease (NAFLD) has been associated with depression and inadequate response to antidepressants. While ketamine has demonstrated efficacy in treating depression, its impact on pre-existing liver injury and depression remains unclear. This study aimed to evaluate the effects of ketamine treatment in a murine model of depression and liver damage, considering age-related differences. Young and aged male C57BL/6N mice were submitted to chronic unpredictable mild stress (CUMS) and methionine–choline-deficient (MCD) diet to induce depressive-like behavior and NAFLD. Behavioral testing (sucrose preference test, open field test, novel object recognition test, Crawley’s sociability test) were used to assess ketamine’s (50 mg/kg) effect on behavior. Hepatic ultrasonography was utilized to evaluate liver status. The cortical and hippocampal NeuN+, GFAP+, and Iba1+ signals were quantified for each animal. Ketamine administration proved effective in relieving anhedonia and anxiety-like behavior, regardless of liver damage. Although ketamine treatment did not improve memory in animals with liver damage, it enhanced sociability, particularly in aged subjects. The acute administration of ketamine did not affect the severity of liver injury, but seems to affect astrogliosis and neuronal loss. Although animal models of depression only replicate certain clinical features of the condition, they remain valuable for evaluating the complex and varied effects of ketamine. By applying such models, we could demonstrate ketamine’s therapeutic versatility, and also indicate that responses to the treatment may differ across different age groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Experimental Research Centre for Normal and Pathological Aging, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Department of Surgery, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Department of Physiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Department of Biophysics, University of Medicine and Pharmacy, 200349 Craiova, Romania.
ORCID-Profile: Eugen Osiac, Bogdan Cătălin
Förderung
- University of Medicine and Pharmacy of Craiova
- University of Medicine and Pharmacy of Craiova, Romania
Zitieren
APA
Mușat, M. I., Ifrim-Predoi, A. M., Mitran, S. I., Osiac, E., & Cătălin, B. (2025). The Behavioral and Neuroinflammatory Impact of Ketamine in a Murine Model of Depression and Liver Damage. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083558
Vancouver
Mușat MI, Ifrim-Predoi AM, Mitran SI, Osiac E, Cătălin B. The Behavioral and Neuroinflammatory Impact of Ketamine in a Murine Model of Depression and Liver Damage. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083558
BibTeX
@article{Muat2025,
author = {Mușat, Mădălina Iuliana and Ifrim-Predoi, Ana-Maria and Mitran, Smaranda Ioana and Osiac, Eugen and Cătălin, Bogdan},
title = {The Behavioral and Neuroinflammatory Impact of Ketamine in a Murine Model of Depression and Liver Damage},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26083558}
}
EUVIMED